---
title: "Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293322586.md"
description: "Danaher reported Q2 FY26 net earnings of $870 million, a 60% year-over-year increase, with revenue rising 5.5% to $6.3 billion. Non-GAAP adjusted diluted EPS grew 8.0% to $1.94. The company raised its full-year 2026 adjusted diluted EPS outlook to $8.45-$8.60 and forecast Q3 non-GAAP core revenue growth of 2.0%-3.0%, citing strong performance in Life Sciences."
datetime: "2026-07-21T10:02:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293322586.md)
  - [en](https://longbridge.com/en/news/293322586.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293322586.md)
generator: "portal-rs"
---

# Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billion

-   Danaher posted Q2 2026 net earnings of USD 870 million, up 60% year-over-year; diluted EPS rose to USD 1.23. \* Revenue increased 5.5% from a year earlier to USD 6.3 billion; non-GAAP core revenue climbed 3.0%. \* Non-GAAP adjusted diluted EPS grew 8.0% to USD 1.94; operating cash flow was USD 1.5 billion. \* Non-GAAP free cash flow totaled USD 1.3 billion; CEO Rainer M. Blair said Life Sciences had its strongest quarter in several years. \* Forecast Q3 non-GAAP core revenue growth of 2.0%-3.0%; raised 2026 adjusted diluted EPS outlook to USD 8.45-8.60. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607210600PR\_NEWS\_USPR\_\_\_\_\_PH08531) on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)

## Related News & Research

- [Northstar Asset Management Inc. Lowers Stock Position in Danaher Corporation $DHR](https://longbridge.com/en/news/297400881.md)
- [WHO grants emergency use listing for Danaher unit Cepheid hemorrhagic fever test](https://longbridge.com/en/news/297938465.md)
- [09:41 ETMammotome Accelerates Production as Public Health Response to Nationwide Breast Biopsy Needle Shortage](https://longbridge.com/en/news/297924402.md)
- [Jefferies Financial Group Inc. Buys New Position in Danaher Corporation $DHR](https://longbridge.com/en/news/297399216.md)
- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**